ShockWave Medical news

ShockWave Medical

ShockWave Medical's GAAP net income for 3 months of 2022 was $14.521 million, compared to a loss of $23.601 million in the previous year. Revenue increased 2.9 times to $93.631 million from $31.9 million a year earlier.

ShockWave Medical

ShockWave Medical's GAAP loss for 2021 was $9.136 million, down 7.3 times from $65.699 million the previous year. Revenue increased 3.5 times to $237.146 million from $67.789 million a year earlier.

ShockWave Medical

ShockWave Medical's GAAP loss for 9M 2021 was $22.078 million, down 2.2 times from $49.825 million in the previous year. Revenue increased 3.4 times to $152.963 million from $45.073 million a year earlier.

ShockWave Medical

ShockWave Medical's GAAP loss for 6M 2021 was $24.026 million, down 34.9% from $36.893 million in the previous year. Revenue increased 3.5 times to $87.808 million from $25.483 million a year earlier.

ShockWave Medical

ShockWave Medical's GAAP loss for three months of 2021 was $23.601 million, up 25.7% from $18.775 million in the previous year. Revenue increased 2.1-fold to $31.9 million from $15.197 million a year earlier.

ShockWave Medical

ShockWave Medical's GAAP loss for 2020 was $65.699 million, up 28.5% from $51.109 million the previous year. Revenue increased 57.9% to $67.789 million from $42.927 million a year earlier.

ShockWave Medical

ShockWave Medical's GAAP loss for 9 months of 2020 was $49.825 million, up 37% from $36.364 million in the previous year. Revenue increased 57.5% to $45.073 million against $28.615 million a year earlier.